You appear to be offline. Some data may be unavailable until your connection is restored.
Description
AbbVie Inc. is a research‑focused biopharmaceutical company that discovers, develops, manufactures and markets prescription medicines and biologics. Its portfolio spans immunology drugs such as Humira, Skyrizi and Rinvoq, oncology therapies including Imbruvica and Venclexta, neuroscience products like Vraylar and migraine treatments, as well as aesthetics brands such as Botox. AbbVie operates in the global pharmaceutical and healthcare sector, emphasizing innovative therapies for complex, chronic diseases. The firm is regarded as a leading U.S. biotech firm, noted for its blockbuster immunology franchise and a growing pipeline across multiple therapeutic areas.
DividendAnnual yield: Percentage of stock price paid annually as dividends.Frequency: How often dividends are paid out (e.g. monthly, quarterly, semi-annual, or annual).Ex-dividend date: Purchase before this date to be eligible for the dividend payment.Payment date: When dividend payments are distributed.Payout: Dividend amount paid per share.Dates marked (est.) are projected from past dividend history.
Dividend history
| Amount | Ex-Date | Payment Date |
|---|---|---|
| $1.73 | Oct 15, 2026 | Nov 16, 2026 |
| $1.73 | Jul 15, 2026 | Aug 14, 2026 |
| $1.73 | Apr 15, 2026 | May 15, 2026 |
Track every ABBV dividend
Get reminders ahead of ABBV's ex-dividend and payment dates, so you always know when distributions are coming. Pair them with price and earnings alerts to keep your full income picture in view.